Cargando…

miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway

miR-21 induces epithelial-mesenchymal transition (EMT) of human cholangiocarcinoma (CCA) cells. However, the mechanism by which this occurs remains unclear. In the present study, high throughput platform was employed to detect the genes that are differential expressed in QBC939 cells transfected wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hai, Huang, Qiang, Jin, Zhi-Yuan, Zhu, Cheng-Lin, Liu, Zhen, Wang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363879/
https://www.ncbi.nlm.nih.gov/pubmed/28197636
http://dx.doi.org/10.3892/ijo.2017.3876
_version_ 1782517227629576192
author Liu, Chen-Hai
Huang, Qiang
Jin, Zhi-Yuan
Zhu, Cheng-Lin
Liu, Zhen
Wang, Chao
author_facet Liu, Chen-Hai
Huang, Qiang
Jin, Zhi-Yuan
Zhu, Cheng-Lin
Liu, Zhen
Wang, Chao
author_sort Liu, Chen-Hai
collection PubMed
description miR-21 induces epithelial-mesenchymal transition (EMT) of human cholangiocarcinoma (CCA) cells. However, the mechanism by which this occurs remains unclear. In the present study, high throughput platform was employed to detect the genes that are differential expressed in QBC939 cells transfected with a hsa-miR-21 antagomir or control vectors. The EMT-related Krüppel-like factor 4 (KLF4) gene was down-regulated after miR-21 was knocked down. Overexpression of miR-21 upregulated KLF4, Akt, ERK and mesenchymal cell markers (N-cadherin and vimentin), downregulated the expression of epithelial cell marker E-cadherin and reduced cell migration and invasion. Immunohistochemistry showed that KLF4, pAkt and pERK were upregulated in tumor xenografts transfected with miR-21 mimics. Inhibitors of the PI3K-Akt and ERK1/2 pathways, LY294002 and U0126, significantly suppressed the EMT phenotype. The present data demonstrated that overexpression of miR-21, accompanied with KLF4, augmented the EMT via inactivation of Akt and ERK1/2 pathways. In conclusion, we have identified a novel mechanism that may be targeted in an attempt to relieve the malignant biological behavior of CCA cells.
format Online
Article
Text
id pubmed-5363879
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-53638792017-04-12 miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway Liu, Chen-Hai Huang, Qiang Jin, Zhi-Yuan Zhu, Cheng-Lin Liu, Zhen Wang, Chao Int J Oncol Articles miR-21 induces epithelial-mesenchymal transition (EMT) of human cholangiocarcinoma (CCA) cells. However, the mechanism by which this occurs remains unclear. In the present study, high throughput platform was employed to detect the genes that are differential expressed in QBC939 cells transfected with a hsa-miR-21 antagomir or control vectors. The EMT-related Krüppel-like factor 4 (KLF4) gene was down-regulated after miR-21 was knocked down. Overexpression of miR-21 upregulated KLF4, Akt, ERK and mesenchymal cell markers (N-cadherin and vimentin), downregulated the expression of epithelial cell marker E-cadherin and reduced cell migration and invasion. Immunohistochemistry showed that KLF4, pAkt and pERK were upregulated in tumor xenografts transfected with miR-21 mimics. Inhibitors of the PI3K-Akt and ERK1/2 pathways, LY294002 and U0126, significantly suppressed the EMT phenotype. The present data demonstrated that overexpression of miR-21, accompanied with KLF4, augmented the EMT via inactivation of Akt and ERK1/2 pathways. In conclusion, we have identified a novel mechanism that may be targeted in an attempt to relieve the malignant biological behavior of CCA cells. D.A. Spandidos 2017-02-14 /pmc/articles/PMC5363879/ /pubmed/28197636 http://dx.doi.org/10.3892/ijo.2017.3876 Text en Copyright: © Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Liu, Chen-Hai
Huang, Qiang
Jin, Zhi-Yuan
Zhu, Cheng-Lin
Liu, Zhen
Wang, Chao
miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title_full miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title_fullStr miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title_full_unstemmed miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title_short miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway
title_sort mir-21 and klf4 jointly augment epithelial-mesenchymal transition via the akt/erk1/2 pathway
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363879/
https://www.ncbi.nlm.nih.gov/pubmed/28197636
http://dx.doi.org/10.3892/ijo.2017.3876
work_keys_str_mv AT liuchenhai mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway
AT huangqiang mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway
AT jinzhiyuan mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway
AT zhuchenglin mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway
AT liuzhen mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway
AT wangchao mir21andklf4jointlyaugmentepithelialmesenchymaltransitionviatheakterk12pathway